Cogent Biosciences (COGT) Shares Outstanding (Weighted Average) (2017 - 2026)

Cogent Biosciences' Shares Outstanding (Weighted Average) history runs 10 years deep, the most recent figure standing at $162.2 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) rose 43.15% year-over-year to $162.2 million; the TTM figure through Mar 2026 stood at $162.2 million (up 43.15% YoY), while the FY2025 annual figure was $128.9 million, up 24.11% from the prior year.
• Shares Outstanding (Weighted Average) was $162.2 million for Q1 2026 at Cogent Biosciences, up from $128.9 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $162.2 million in Q1 2026 to a low of $77050.0 in Q2 2023.
• Historically, Shares Outstanding (Weighted Average) has averaged $82.9 million across 5 years, with a median of $95.9 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Weighted Average) plunged 99.86% in 2023, then soared 129998.76% in 2024.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $58.7 million in 2022, then soared by 35.61% to $79.7 million in 2023, then soared by 30.38% to $103.9 million in 2024, then advanced by 24.11% to $128.9 million in 2025, then climbed by 25.83% to $162.2 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $162.2 million (Q1 2026), $128.9 million (Q4 2025), and $121.9 million (Q3 2025), per Business Quant data.